Akèy › Ipèplazi adrèn kongènital
Etid klinik pou Ipèplazi adrèn kongènital ap rekrite nan Etazini
8 etid pou Ipèplazi adrèn kongènital ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
- Illinois3 etid
- Kalifòni3 etid
- Maryland3 etid
- Michigan4 etid
- Minnesota5 etid
- Pennsylvania3 etid
- Texas3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
Ap rekriteFaz 2/3
Laj 1 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT07159841A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 30, 2026 · NCT07144163Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07138274Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
Ap rekriteFaz 2
3 Months – 47 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT07536269Natural History Study of Patients With Excess Androgen
Ap rekriteEtid obsèvasyon
1 Day – 99 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT00250159A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Mar 9, 2026 · NCT05669950Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT07247058Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 11, 2026 · NCT07104812Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.